Gene therapy: no new ethical issues

    Bulletin of Medical Ethics
    |June 1, 1992
    PubMed

    Insights

    This meeting discussed the ethical considerations of gene therapy, referencing the Clothier Report. Experts from diverse fields gathered to review findings on human reproduction and genetic advancements.

    Area of Science:

    • Sociology
    • Bioethics
    • Human Reproduction

    Background:

    • A day school was organized by the Human Reproduction Study Group of the British Sociological Association.
    • The meeting focused on the ethical implications of gene therapy.
    • Key discussions referenced the findings of the Clothier Report.

    Purpose of the Study:

    • To review and discuss the ethical considerations of gene therapy.
    • To bring together professionals and academics from various disciplines.
    • To analyze the societal impact of advancements in human reproduction.

    Main Methods:

    • A day school event was held.
    • Discussions were informed by the Report of the Committee on the Ethics of Gene Therapy.
    • Expert participants represented diverse professional and academic backgrounds.

    Main Results:

    • The meeting facilitated a multidisciplinary discussion on gene therapy ethics.
    • Participants engaged with the findings of the Clothier Report.
    • The event highlighted the need for continued dialogue on the ethics of human reproduction.

    Conclusions:

    • Ethical oversight in gene therapy requires broad, interdisciplinary input.
    • Societal implications of reproductive technologies necessitate careful consideration.
    • Ongoing evaluation of ethical guidelines is crucial for advancing human reproduction research.

    Related Concept Videos

    What is Genetic Engineering?00:49

    What is Genetic Engineering?

    Overview
    Gene Therapy00:59

    Gene Therapy

    Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be inserted. The...
    CRISPR01:59

    CRISPR

    Genome editing technologies allow scientists to modify an organism’s DNA via the addition, removal, or rearrangement of genetic material at specific genomic locations. These types of techniques could potentially be used to cure genetic disorders such as hemophilia and sickle cell anemia. One popular and widely used DNA-editing research tool that could lead to safe and effective cures for genetic disorders is the CRISPR-Cas9 system. CRISPR-Cas9 stands for Clustered Regularly Interspaced Short...
    Gene Therapy00:59

    Gene Therapy

    Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be inserted. The...
    Embryonic Stem Cells00:57

    Embryonic Stem Cells

    Embryonic stem (ES) cells were first discovered in mice in 1981 by Martin Evans. In 1998, James Thomson identified a method to isolate embryonic stem cells from humans. Human embryonic stem cells (hESCs) are obtained from 3-5 day old embryos that remain unused after an in vitro fertilization procedure.
    ES cells are grown in a culture medium where they can divide indefinitely, creating ES cell lines. Under certain conditions, ES cells can differentiate, either spontaneously into a variety of...
    Pharmacogenomics: Identification of New Drug Targets01:29

    Pharmacogenomics: Identification of New Drug Targets

    Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...